HFA-ESC 2026 Digoxin Shows Signs of a Heart Failure Revival New trial data from the Heart Failure 2026 conference suggest that low-dose digoxin may reduce worsening HF events, reigniting debate over ...
The second dose of Shingrix, a vaccine approved by the FDA for adults ages 50 and older, often causes side effects like muscle pain, chills, fatigue, and headache. These symptoms are more common with ...
SCAI 2026 Atrial-Fixation TMVR Appears Feasible, Durable at 1 Year Early feasibility study results are promising for AltaValve, which is designed with a novel atrial fixation system to minimize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results